Paralytic poliomyelitis in vaccinated children
Paralytic poliomyelitis were observed in two healthy children who both had previously received four doses of standard inactivated poliovaccine (IPV). These children, whose immune defenses were normal, failed to respond to IPV. This absence of antibody response might be related to an insufficient antigenicity of inactivated vaccines, justifying the extensive use of the more potent IPV, now produced on continuous cell lines.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1987 |
|---|---|
| Erschienen: |
1987 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Neuropediatrics - 18(1987), 3 vom: 28. Aug., Seite 153-4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dussaix, E [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.12.1987 Date Revised 16.01.2008 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM036650064 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM036650064 | ||
| 003 | DE-627 | ||
| 005 | 20231221135410.0 | ||
| 007 | tu | ||
| 008 | 231221s1987 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0122.xml |
| 035 | |a (DE-627)NLM036650064 | ||
| 035 | |a (NLM)3683754 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dussaix, E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Paralytic poliomyelitis in vaccinated children |
| 264 | 1 | |c 1987 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.1987 | ||
| 500 | |a Date Revised 16.01.2008 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Paralytic poliomyelitis were observed in two healthy children who both had previously received four doses of standard inactivated poliovaccine (IPV). These children, whose immune defenses were normal, failed to respond to IPV. This absence of antibody response might be related to an insufficient antigenicity of inactivated vaccines, justifying the extensive use of the more potent IPV, now produced on continuous cell lines | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Poliovirus Vaccine, Inactivated |2 NLM | |
| 700 | 1 | |a Huault, G |e verfasserin |4 aut | |
| 700 | 1 | |a Landrieu, P |e verfasserin |4 aut | |
| 700 | 1 | |a Tardieu, M |e verfasserin |4 aut | |
| 700 | 1 | |a Lebon, P |e verfasserin |4 aut | |
| 700 | 1 | |a Menetrat, J L |e verfasserin |4 aut | |
| 700 | 1 | |a Celers, J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuropediatrics |d 1993 |g 18(1987), 3 vom: 28. Aug., Seite 153-4 |w (DE-627)NLM012996483 |x 1439-1899 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:1987 |g number:3 |g day:28 |g month:08 |g pages:153-4 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 1987 |e 3 |b 28 |c 08 |h 153-4 | ||